This article was originally published on Dec. 5.
Claremont BioSolutions said today that it has reached an agreement with Bioquote Limited to distribute in the UK and Ireland its products for cell lysis, DNA extraction and isolation, and His-tagged protein purification.
Claremont said that the distribution agreement extends its reach into European markets.
Based in Upland, Calif., Claremont specializes in disposable devices for improving sample prep in DNA diagnostics. The company's proprietary devices use micromotors to perform mechanical cell lysis and DNA purification. These devices prepare samples for DNA analysis in less than five minutes and without any extraneous instruments, and can be easily incorporated into sample-to-answer and lab-on-a-chip cartridges for point-of-care nucleic acid testing, the company said.
The first products to be marketed under the agreement will be Claremont's Omnilyse lysis kits and PureLyse DNA extraction kits.